Cargando…
Case Report: Apremilast for Therapy-Resistant Pemphigus Vulgaris
BACKGROUND: In pemphigus, elucidating the disease-causing immune mechanism and developing new therapeutic strategies are needed. In this context, the second messenger 3′,5′-cyclic adenosine monophosphate (cAMP) is gaining attention. cAMP is important in hematological and auto-inflammatory disorders....
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653172/ https://www.ncbi.nlm.nih.gov/pubmed/33193415 http://dx.doi.org/10.3389/fimmu.2020.588315 |